Susquehanna Portfolio Strategies’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.02M Sell
269,967
-40,680
-13% -$438K 0.06% 323
2026
Q1
$2.63M Buy
310,647
+199,807
+180% +$2.19M 0.04% 435
2025
Q4
$1.25M Sell
110,840
-68,070
-38% -$843K 0.02% 600
2025
Q3
$2.69M Buy
178,910
+93,940
+111% +$1.37M 0.04% 447
2025
Q2
$1.2M Buy
+84,970
New +$1.51M 0.03% 474
2024
Q4
Sell
-20,807
Closed -$1.04M 57
2024
Q3
$1.04M Sell
20,807
-6,420
-24% -$250K 0.07% 193
2024
Q2
$945K Sell
27,227
-9,000
-25% -$356K 0.04% 296
2024
Q1
$1.98M Hold
36,227
0.05% 340
2023
Q4
$1.55M Buy
+36,227
New +$1.13M 0.03% 494

Other funds holding BHVN

Susquehanna Portfolio Strategies's BHVN Position: Q2 2026 in Review

Susquehanna Portfolio Strategies reduced its Biohaven (BHVN) stake by 13% in Q2 2026, selling an estimated $438K and leaving 269,967 shares worth $4.02M. The position accounts for 0.06% of the portfolio, ranked #323.

Susquehanna Portfolio Strategies first reported a position in BHVN in Q4 2023 and has held it in 9 quarters since. 292 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Susquehanna Portfolio Strategies held 269,967 shares of Biohaven worth $4.02M as of Q2 2026.
  • Susquehanna Portfolio Strategies sold 40,680 Biohaven shares in Q2 2026, an estimated $438K.
  • Biohaven made up 0.06% of Susquehanna Portfolio Strategies's portfolio in Q2 2026, its #323 holding.
  • Susquehanna Portfolio Strategies first reported a position in Biohaven in Q4 2023 and has held it in 9 quarters since.
  • 292 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.